Action of nonviral gene delivery vectors on human complement system: Low anticomplementary activity of lipoplexes based on LacZ plasmid and phospholipid/oligocation liposomes

Cytobios

Volumn 413, Issue 1 SUPPL., 2001, Pages 67-74

  Kozlov, L V ^a   Zhdanov, R I ^b   Guzova, V A ^a   Podobed, O V ^b   Sviridov, Yu V ^b   Bogdanenko, E V ^a   Shvets, V I ^a   Dyabina, O S ^b   Ermakov, A S ^b  

^a GN Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

C3 convertase; Complement activation; Gene therapy; Injectable nonviral vectors; Phospholipid liposomes; Polycation

Indexed keywords

CARDIOLIPIN; COMPLEMENT; COMPLEMENT COMPONENT C4; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL; ARTICLE; DRUG EFFECT; GENE TRANSFER; GENE VECTOR; GUINEA PIG; HEMOLYSIS; HUMAN; IMMUNOLOGY; PLASMID; SHEEP; STANDARD;

ANIMALS; CARDIOLIPINS; COMPLEMENT C4; COMPLEMENT SYSTEM PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GUINEA PIGS; HEMOLYSIS; HUMANS; LIPOSOMES; PHOSPHATIDYLCHOLINES; PLASMIDS; SHEEP;

EID: 0035232633     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BRADLEY A. J., Brooks D. E., Norris-Jones R. and Devine D. V. 1999. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Biochim. biophys. Acta 1418 19-30.
2. CHONN A., Cullis P. R. and Devine D. V. 1991. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146 4234-41.
3. CICHON G. and Strauss M. 1997. The liver as a target for gene therapy. In Concepts in Gene Therapy. pp 268-81. Edited by M. Strauss and J. A. Barranger. De Gruyter.
4. DUZGUNES N., Wilschut J., Hong K., Fraley R., Perry C., Friend D. S., James T. L. and Papahadjopoulos D. 1983. Physicochemical characterization of large unilamellar phospholipid vesicles prepared by reverse-phase evaporation. Biochim. biophys. Acta 732 289-99.
5. HARRISON R. A. and Lachmann P. J. 1986. Complement technology. In Handbook of Experimental Immunology. Fourth editn. Vol 1. Immunochemistry. Edited by D. M. Weir and L. A. Herzenberg. Blackwell Science Publications.
6. JIANG H., Cooper B., Robey F. A. and Gewurz H. 1992. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J. biol. Chem. 267 25597-601.
7. KOZLOV L. V., Lakhtin V. M., Skorokhodova T. G., Batalova T. N., Shojbonov B. B., D'yakov V. L., Guzova V. A. and Matveevskaya N. S. 2000. Competition for covalent binding with nascent C4b complement. Bioorg. Khim. 26 817-24.
8. KOZLOV L. V. and Lebedeva T. V. 1998. Inhibition of the formation of complement C5-convertase. Bioorg. Khim. 24 350-5.
9. KOZLOV L. V., Krylova Yu. I., Chikh V. P. and Molchanova N. N. 1982. Modified methods for testing of functional activity of complement factors C2, C3, C4 and C5. Bioorg. Khim. 8 652-9.
10. LASIC D. D. 1997. Genosomes in gene therapy. CRC Press, Boca Raton, Florida, U.S.A.
11. MARJAN J., Xie Z. and Devine D. V. 1994. Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. biophys. Acta 1192 35-44.
12. PLANK C., Mechtler K., Szoka F. C. Jr and Wagner E. 1996. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7 1437-46.
13. PODOBED O. V. and Zhdanov R. I. 1999. Gene transfer with non-viral vectors based on polycations and hydrophobic polycations for addressed gene therapy. Voprosy Biol. Med. Farm. Khim. 4 7-14 (In Russian).
14. RUSSELL D. W., Berger M. S. and Miller A. D. 1995. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum. Gene Ther. 6 635-41.
15. SANDIG V., Hofmann C., Steinert S., Jennings G., Schlag P. and Strauss M. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7 1937-45.
16. ZHDANOV R. I., Starzhevskaya N. B., Struchkov V. A. and Dyabina O. S. 2001. Chromatin-bound cardiolipin - the phospholipid of proliferation. Cytobios 106 55-61.
17. ZWIRNER J., Dobos G. and Gotze O. 1995. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes. J. Immunol. Meth. 186 55-63.